NextRegenX
NextRegenX 2025 International Next-Generation Advanced Regenerative Medicine Industry Exhibition
NextRegenX 2025 is Korea’s first exhibition dedicated to the advanced regenerative medicine industry, following the global trend of specialized regenerative medicine exhibitions established in Japan, the United States, and Europe. Covering core regenerative medicine technologies — including cell and gene therapy, tissue engineering, and biomaterials — as well as next-generation convergence technologies such as AI-based precision medicine, NextRegenX serves as an innovation platform that connects cutting-edge industry technologies with real-world clinical applications, offering valuable opportunities for business partnerships and future growth through networking with industry leaders.
- Why NextRegenX 2025?
- Connect with Global Industry Leaders
- Share the latest technologies and market trends, and establish secure collaborations with global biopharmaceutical companies, research institutes, investors, and regulatory authorities.
- Explore Cutting-Edge Regenerative Medicine Technologies
- An overview of cutting-edge regenerative medicine technologies and industry innovations, including cell and gene therapy, tissue engineering, 3D bioprinting, biomaterials, and AI-based precision medicine.
- Expand Your Business with B2B Networking & Partnerships
- Build partnerships and explore new business opportunities through 1:1 business matching with prominent industry representatives, including CMOs, CDMOs, CROs, and Investors.
- Gain Insights from Leading Global Forums & Conferences
- Explore the latest global trends in clinical and regulatory strategies, investment, and industrial innovation at the International Forum on Advanced Regenerative Medicine Development Strategies and the Open Innovation Investment Conference.
- Unlock Global Collaboration & New Business Opportunities
- Build international partnerships and drive new business opportunities in a global hub for regenerative medicine that fosters collaboration across R&D, industry, and investment.
EXHIBITS
-
- Cell and Gene Therapies
-
- Immune Cell Therapies (T Cells, NK Cells, etc.)
- Next-Generation Cell and Gene Therapies (CAR-T, iPSC-derived Therapies)
- Gene Editing Technologies (CRISPR, TALEN, etc.)
- Gene Delivery Systems (AAV, Lentiviral Vectors, etc.)
- Stem Cell Therapies (Adult Stem Cells, Embryonic Stem Cells)
-
- Innovative Tissue Regeneration and Biomaterials
-
- 3D Bioprinting and Tissue Engineering
- Biocompatible Scaffolds
- Biomaterials
- Customized Tissue Fabrication and Transplantation Technologies
-
- Precision Regenerative Medicine and Personalized Therapies
-
- Personalized Therapeutics Platforms
- Immune Cell-Based Precision Therapies
- Microbiome-Based Regenerative Medicine
- Digital Health-Based Therapeutic Solutions
-
- Advanced Biomanufacturing and Processing Technologies
-
- GMP-Compliant Production Systems for CGT (Cell and Gene Therapies)
- Automated Cell Culture and Monitoring Systems
- Bioreactors and Single-Use Bioprocessing Technologies
- Cell Culture and Expansion Solutions
- Quality Assurance and Quality Control (QA/QC)
-
- Digital Regenerative Medicine and AI-Driven Solutions
-
- AI-Driven Drug Discovery and Development
- Digital Biobank
- Data-Driven Therapeutic Models
- Bio Big Data
- Digital Biomarkers
- Therapeutic Optimization Solutions
-
- Anti-Aging & Aesthetic Regenerative Technologies
-
- Global and Domestic Regulatory and Policy Trends
- Exosome-Based Regenerative and Anti-Aging Biopharmaceutical Technologies
- Microbiome-Based Skin Rejuvenation Solutions
- Precision Diagnostic Platforms Based on Aging Biomarkers
- Antioxidant Biomaterials and Tissue Regeneration Applications
-
- Regulatory & Market Access Strategies
-
- Global and Domestic Regulatory and Policy Trends
- Quality and Safety Standards
- Clinical Research and Treatment Design in Advanced RM
- Clinical Trial Design for Biologics Commercialization
- Building Global Collaboration Frameworks
-
- Hospital-Industry Clinical Collaboration Platforms
-
- Hospital-Industry Joint Clinical Research & Collaboration Models Clinical Partnering Models for Commercialization of Regenerative Medicine
EVENTS (upcoming)
|
CONFERENCE / FORUM |
|---|
|
|
IR / TECHNOLOGY TRANSACTION |
|
|
NETWORKING |
|
KYUNGYON EXHIBITION CORP.